Industry Focus Transcripts

Insurers report strong Q1 results despite Obamacare losses; Fresenius plants an Akorn; and Express Scripts' battle with Anthem gets real.

Terrible fourth-quarter results, a slew of store closures, and bankruptcies have led to the perception that brick-and-mortar retail is experiencing a slow death. However, opportunities abound for retailers willing to adapt and evolve.

Bad news for oil producers; great news for oil pipeline operators.

Fracking has really taken off in the past few years, but how does it work? Our energy analysts explain the ins and outs and name a few of the best companies investors will want to look at.

It’s big pharma week! First, we discuss Eli Lilly’s second-quarter earnings and its decision to spin off its animal health business. Then, we explain why GlaxoSmithKline became an investor in the DNA screening company 23andMe.

The surveying platform is popular, but that doesn’t make the tech company a solid business.

Diving into tax legislation, bank regulations, mortgages, and more.

Catching up on the Excaliburger food truck dynamo's unpredictable adventures since we saw him last.

Here are four small-cap banks that probably aren't on your radar yet, and here's what Amazon Pay could mean to PayPal and its other competitors.

If all you heard about EVs was Tesla's drama, you might think the industry was doomed. Far from it! Investors won’t want to miss these solid, promising opportunities.

The stock market's November swoon has put these top healthcare stocks on sale.

Here's what's happening this week in the financials sector.

Four Fools discuss all things marijuana, including what excites them most, what keeps them up at night, and what stocks are their favorites.

Real risk accompanies all three.

And it’s probably not dying any time soon. But the cable space is definitely changing in some major ways.

Want a 12% return on investment for greening up your house? Solar panels might be the way to go.

The Apple-Microsoft rivalry is getting a gritty modern reboot as both companies battle for that $1 trillion market cap.

On top of blowout sales of the Switch, fast-growing opportunities in mobile and digital are breathing new life into this stock.

Positive trial data unveiled at the American Society of Hematology conference makes these top stocks to watch in 2019.

In a world of “dying newspapers”, the Gray Lady is evolving into a content platform for the future.